Learn More
Medchemexpress LLC LY3522348 | 2568608-48-8 | 98.3% | 409.41 | 50 MG

Supplier: Medchemexpress LLC HY14998750MG
LY3522348 (KHK-IN-3) is an inhibitor of ketohexokinase (KHK), a rate-limiting enzyme and fructokinase involved in fructose metabolism. KHK catalyzes the phosphorylation of fructose to fructose-1-phosphate (FIP) at the expense of ATP. The lack of feedback inhibition in fructose metabolism leads to the accumulation of downstream intermediates, contributing to lipogenesis, gluconeogenesis, and oxidative phosphorylation.
- KHK inhibitor.
- Can be utilized in studies related to kidney disease.
- Applicable in research concerning nonalcoholic steatohepatitis (NASH).
- Useful in diabetes research.
- Can be used to study heart failure.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.